Dose Finding Study of Nemiralisib (GSK2269557) in Subjects With an Acute Moderate or Severe Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)
Clinical trial NCT03345407 · TERMINATED
Trial details
- NCT number
- NCT03345407
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-28
- Primary completion
- 2019-01-10
- Enrollment
- 943
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.